Ma ZM - Search Results

1

Mutational analysis revealed that conservation of hepatitis B virus reverse transcriptase residue 306 (rtP306) is crucial for encapsidation of pregenomic RNA.

Wang YX, Xu X, Luo C, Ma ZM, Jiang HL, Ding JP, Wen YM. Wang YX, et al. Among authors: ma zm. FEBS Lett. 2007 Feb 6;581(3):558-64. doi: 10.1016/j.febslet.2007.01.024. Epub 2007 Jan 18. FEBS Lett. 2007. PMID: 17254572 Free article.

2

Substitution of proline 306 in the reverse transcriptase domain of hepatitis B virus regulates replication.

Lin X, Ma ZM, Yao X, He LF, Yuan ZH, Ding JP, Wen YM. Lin X, et al. Among authors: ma zm. J Gen Virol. 2005 Jan;86(Pt 1):85-90. doi: 10.1099/vir.0.80581-0. J Gen Virol. 2005. PMID: 15604434

3

High replicative full-length lamivudine-resistant hepatitis B virus isolated during acute exacerbations.

Zhang JM, Yao X, Wang YX, Liu F, Ma ZM, Weng XH, Wen YM. Zhang JM, et al. Among authors: ma zm. J Med Virol. 2005 Oct;77(2):203-8. doi: 10.1002/jmv.20453. J Med Virol. 2005. PMID: 16121368

4

A putative new domain target for anti-hepatitis B virus: residues flanking hepatitis B virus reverse transcriptase residue 306 (rtP306).

Wang YX, Xu X, Luo C, Ma ZM, Jiang HL, Ding JP, Wen YM. Wang YX, et al. Among authors: ma zm. J Med Virol. 2007 Jun;79(6):676-82. doi: 10.1002/jmv.20835. J Med Virol. 2007. PMID: 17457904

5

A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.

Ma ZM, Lin X, Wang YX, Tian XC, Xie YH, Wen YM. Ma ZM, et al. J Med Virol. 2009 Feb;81(2):230-7. doi: 10.1002/jmv.21393. J Med Virol. 2009. PMID: 19107969

6

Replication efficiency and sequence analysis of full-length hepatitis B virus isolates from hepatocellular carcinoma tissues.

Lin X, Ma ZM, Yao X, Zhang YP, Wen YM. Lin X, et al. Among authors: ma zm. Int J Cancer. 2002 Dec 10;102(5):487-91. doi: 10.1002/ijc.10733. Int J Cancer. 2002. PMID: 12432551

7

Gene-expression profiles of a hepatitis B small surface antigen-secreting cell line reveal upregulation of lymphoid enhancer-binding factor 1.

Tian X, Zhao C, Ren J, Ma ZM, Xie YH, Wen YM. Tian X, et al. Among authors: ma zm. J Gen Virol. 2007 Nov;88(Pt 11):2966-2976. doi: 10.1099/vir.0.83108-0. J Gen Virol. 2007. PMID: 17947518

8

Recombinant vaccinia virus expressing Pre-S/S protein of duck hepatitis B virus and its preliminary use for treatment of persistent infection.

Ma ZM, Kong YY, Wang Y, Wen YM. Ma ZM, et al. Acta Virol. 1996 Nov-Dec;40(5-6):311-4. Acta Virol. 1996. PMID: 9171461

9

Replicative efficiency and pathogenicity of hepatitis B virus e-minus precore variant.

Wen YM, Ma ZM, Tu G, Zhai WR, He LF, Yao X. Wen YM, et al. Among authors: ma zm. J Gastroenterol Hepatol. 1998 Nov;13(S3):S304-S307. doi: 10.1111/j.1440-1746.1998.tb01898.x. J Gastroenterol Hepatol. 1998. PMID: 28976680

10

Experimental study on pathogenicity of precore mutants in Hepadnaviridae.

Ma Z, Wen Y, Xiong S, Zhai W, He L, Yao X. Ma Z, et al. Chin Med J (Engl). 1998 Jun;111(6):519-23. Chin Med J (Engl). 1998. PMID: 11245071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters